Updated Jul 16, 2026
Blass Devin has filed 2 SEC Form 4 filings across 1 company in the last 90 days.
Devin Blass is the Chief Technology Officer and Senior Vice President of CMC at Longeveron Inc., a clinical-stage biotechnology company focused on regenerative medicine. He has been involved in the company's development of therapies aimed at addressing aging-related conditions.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-07 | LGVN | Longeveron Inc. | F — Tax withholding / forfeiture | 15.8K | $0.73 | $12K |
| 2026-05-05 | LGVN | Longeveron Inc. | A — Grant or award | 250.0K | $0.00 | |
| 2026-04-03 | LGVN | Longeveron Inc. | F — Tax withholding / forfeiture | 8.6K | $1.12 | $10K |
| 2025-10-01 | LGVN | Longeveron Inc. | F — Tax withholding / forfeiture | 7.6K | $0.74 | $6K |
| 2025-07-15 | LGVN | Longeveron Inc. | A — Grant or award | 102.0K | $0.00 | |
| 2025-07-01 | LGVN | Longeveron Inc. | F — Tax withholding / forfeiture | 4.6K | $1.28 | $6K |
Devin Blass is the Chief Technology Officer and Senior Vice President of CMC at Longeveron Inc., a clinical-stage biotechnology company focused on regenerative medicine. He has been involved in the company's development of therapies aimed at addressing aging-related conditions.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Blass Devin profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.